A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer
Withdrawn
- Conditions
- Cancer
- Registration Number
- NCT02598479
- Lead Sponsor
- Best Answer for Cancer Foundation
- Brief Summary
The IPTLD QoL Broad Study.
- Detailed Description
A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- diagnosis of cancer,
- age older than 18 years,
- requesting IPTLD and nutrition therapy
Exclusion Criteria
- diagnosis other than cancer,
- age younger than 18 years,
- requesting conventional chemotherapy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in Quality of Life measured by questionnaires 5 years Improvement in Quality of Life using Insulin Potentiation Low Dose Chemotherapy and Nutrition Therapy for the Treatment of Cancer, as measured by MD Anderson's MDASI questionnaires
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Arizona Center for Advanced Medicine
🇺🇸Scottsdale, Arizona, United States
Arizona Center for Advanced Medicine🇺🇸Scottsdale, Arizona, United States